MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Clinical subtypes and Radiological patterns in Progressive supranuclear palsy: A Prospective study

    K. Gulati, S. Pandey (Faridabad, India)

    Objective: To subclassify Progressive supranuclear palsy (PSP) into cortical and subcortical typesTo identify the clinical and radiological correlation in PSP Background: The 2017 International Parkinson…
  • 2025 International Congress

    Multiscale entropy: a New Oculomotor Measure of PSP.

    C. O'Keeffe, A. Gallagher, J. Inocentes, B. Coe, B. White, D. Brien, D. Munoz, R. Walsh, T. Lynch, C. Fearon (Dublin, Ireland)

    Objective: The objective of this study was investigate whether multiscale entropy, a measure of complexity, when applied to the path of unconstrained eye movements could…
  • 2025 International Congress

    Brain Cholinergic Changes in Progressive supranuclear palsy: A single-subject voxel-wise approach to understanding heterogeneity

    P. Kanel, G. Carli, J. Barr, R. Vangel, A. Narkis, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)

    Objective: To characterize individual-level topographical patterns of cholinergic changes compared to controls in Progressive Supranuclear Palsy (PSP) using a voxel-wise approach. Background: The cholinergic system…
  • 2025 International Congress

    Neuroprotective efficacy of EDTA against manganese neurotoxicity: Implications for modulating Parkinsonian syndromes

    H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

    Objective: This study investigates the neuroprotective potential of ethylenediaminetetraacetic acid (EDTA) in reducing the neurotoxic effects of manganese (Mn), focusing on both motor and non-motor…
  • 2025 International Congress

    Description possible enviromental exposure in AMS Latin America population

    M. Cesarini, N. Gonzalez Rojas, M. Espindola, G. da Prat, JL. Etcheverry, E. Gatto (Buenos Aires, Argentina)

    Objective: To identify possible risk factors such as environmental exposures in subjects diagnosed with MSA from referral centres in Latin America (Pan-American MSA Study Group)…
  • 2025 International Congress

    Neurologic Music Therapy and Non-Invasive Brain Stimulation for Upper Extremity Performance in Patients with Corticobasal Syndrome

    K. Kang, I. Sterner, S. Bakhshi, C. Bedell, A. Pantelyat (Baltimore, USA)

    Objective: To explore the effects of Neurologic Music Therapy (NMT) with or without non-invasive brain stimulation on upper limb performance in patients with corticobasal syndrome…
  • 2025 International Congress

    Real-World Adverse Event Profile in Children and Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists (D2RAs) Compared With Non-D2RAs

    K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Bethesda, USA)

    Objective: To further explore the safety profile of dopamine D2 receptor antagonists (D2RAs) for Tourette syndrome (TS) in a community setting. Background: D2RAs (aripiprazole/haloperidol/pimozide) are…
  • 2025 International Congress

    Antisense Oligonucleotide Treatment in Ataxia-Telangiectasia

    C. de Gusmao, C. Achkar, B. Ahtam, C. Berde, L. Bush, D. Chin, B. Darras, K. Faour, D. Friedmann, B. Gagoski, B. Goodlett, E. Grant, A. Gupta, S. Hills, A. Hu, J. Kim, A. Kuniholm, C. Lentucci, J. Lopes, E. Lopez, A. Luddy, B. Margus, M. Meserve, V. Natale, T. Nakayama, A. O’Connor, C. Rabideau, O. Riccardi, R. Schule, E. Sherril, L. Solo, A. Soucy, V. Suslovitch, M. Synofzik, J. Thornton, T. Yu (Boston, USA)

    Objective: Describe results of an antisense oligonucleotide (ASO) treatment trial in a patient with ataxia-telangiectasia (AT). Background: AT is a neurodegenerative, incurable disease of children…
  • 2025 International Congress

    Movement disorders as a manifestation of aceruloplasminemia a case report

    A. Camargo (Bogota, Colombia)

    Objective: To develop a step-by-step diagnostic approach to aceruloplasminemia with initial presentation of movement disorders Background: Aceruloplasminemia is a rare iron overload disorder with autosomal…
  • 2025 International Congress

    Potential Disease-Modifying Effects in Mild Parkinson’s Disease following High Intensity Aerobic Exercise: a Case Report

    L. Goh, N. Allen, G. Angelis, S. Meikle, N. Johnson, J. Lv, C. Sue, S. Paul (Camperdown, Australia)

    Objective: To describe the effects of high intensity aerobic exercise in an individual with mild Parkinson’s disease (PD). Background: Emerging evidence suggests high intensity aerobic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25111 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley